These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8726416)

  • 1. Antitumor effect in cyclosporine A- or FK506-treated mice after syngeneic bone marrow transplantation.
    Hashino S; Imamura M; Tanaka J; Kasai M; Higa T; Asaka M
    Leuk Lymphoma; 1996 Apr; 21(3-4):331-7. PubMed ID: 8726416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism of interleukin-2 and cyclosporine A in induction of a graft-versus-tumor effect without graft-versus-host disease after syngeneic bone marrow transplantation.
    Charak BS; Agah R; Mazumder A
    Blood; 1992 Jul; 80(1):179-84. PubMed ID: 1611084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression.
    Han CW; Imamura M; Hashino S; Zhu X; Tanaka J; Imai K; Matsudaira T; Asano S
    Bone Marrow Transplant; 1995 May; 15(5):733-9. PubMed ID: 7545487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
    Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
    J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK 506 inhibits severe graft-versus-host disease without mediating cytokine balance and/or cytotoxic molecules.
    Imamura M; Tao HR; Hashino S; Kobayashi S; Mori A; Kobayashi M; Asaka M; Tanaka J
    Transplant Proc; 2000 Nov; 32(7):2448-9. PubMed ID: 11120238
    [No Abstract]   [Full Text] [Related]  

  • 6. Tacrolimus/Methotrexate versus cyclosporine/methotrexate as graft-versus-host disease prophylaxis in patients with severe aplastic anemia who received bone marrow transplantation from unrelated donors: results of matched pair analysis.
    Yagasaki H; Kojima S; Yabe H; Kato K; Kigasawa H; Sakamaki H; Tsuchida M; Kato S; Kawase T; Muramatsu H; Morishima Y; Kodera Y
    Biol Blood Marrow Transplant; 2009 Dec; 15(12):1603-8. PubMed ID: 19896085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.
    Blazar BR; Taylor PA; Fitzsimmons WE; Vallera DA
    J Immunol; 1994 Aug; 153(4):1836-46. PubMed ID: 7519216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-15 is decreased upon CsA and FK506 treatment of acute rejection following heart transplantation in mice.
    Yu Z; Zhou X; Yu S; Xie H; Zheng S
    Mol Med Rep; 2015 Jan; 11(1):37-42. PubMed ID: 25333459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine A inhibits the mRNA expressions of IL-2, IL-4 and IFN-gamma, but not TNF-alpha, in canine mononuclear cells.
    Kobayashi T; Momoi Y; Iwasaki T
    J Vet Med Sci; 2007 Sep; 69(9):887-92. PubMed ID: 17917372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FK506 inhibits severe graft-versus-host disease without mediating the involvement of perforin and granzyme B.
    Tao HR
    Hokkaido Igaku Zasshi; 1998 May; 73(3):227-37. PubMed ID: 9719949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of cytokine gene suppression by the equivalent effective doses of cyclosporine and tacrolimus in rat heart allografts.
    Jiang H; Yang X; Soriano RN; Fujimura T; Krishnan K; Kobayashi M
    Immunobiology; 2000 Sep; 202(3):280-92. PubMed ID: 11045663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of CD4+ T cells in the colon of CsA-treated mice following myeloablative conditioning and bone marrow transplantation.
    Perez J; Brandon JA; Cohen DA; Jennings CD; Kaplan AM; Bryson JS
    Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G843-52. PubMed ID: 21292993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunosuppressive effect in combination therapy of cyclosporine A, FK506 and 15-deoxyspergualin on a pancreatic islet xenotransplantation].
    Ueno M; Nakajima Y; Kanehiro H; Yoshimura A; Nakano H
    Nihon Geka Gakkai Zasshi; 1993 Apr; 94(4):376-82. PubMed ID: 7686615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of in vitro and in vivo immunosuppressive potential of cyclosporin G with cyclosporin A and FK-506.
    Saada V; Pham-Huy C; Voisin J; Righenzi S; Rucay P; Claude JR; Duc HT
    Int J Immunopharmacol; 1996 Jan; 18(1):79-87. PubMed ID: 8732436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
    Ohajekwe OA; James T; Hardy MA; Oluwole SF
    Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease.
    Flanagan DL; Jennings CD; Bryson JS
    J Immunol; 1999 Aug; 163(3):1170-7. PubMed ID: 10415011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of graft versus leukemia effects by cell-mediated lymphokine-activated immunotherapy after syngeneic bone marrow transplantation in murine B cell leukemia.
    Weiss L; Nusair S; Reich S; Sidi H; Slavin S
    Cancer Immunol Immunother; 1996 Oct; 43(2):103-8. PubMed ID: 8954144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats.
    Markus PM; Cai X; Ming W; Demetris AJ; Fung JJ; Starzl TE
    Surgery; 1991 Aug; 110(2):357-63; discussion 363-4. PubMed ID: 1713358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin A.
    Liem LM; van Noort JT; Goulmy E
    Bone Marrow Transplant; 1996 Jul; 18(1):73-8. PubMed ID: 8831998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.